If you’ve got $10,000 for investment, here’s how Cramer would put that money to work, right here and right now.» Read More
There are reports this morning that Fannie Mae has won the capital relief some have asked for. At 9 am OFHEO (Office of Federal Housing Enterprise Oversight--Fannie's regulator) has scheduled a conference call to discuss alleviating some of the capital constraints on Fannie and Freddie.
General Mills on Wednesday posted higher quarterly profit as cost-cutting measures and higher sales helped offset soaring prices for wheat and other commodities.
The Federal Reserve cut the fed funds rate by three-quarters of a point, to 2.25 percent. CNBC asked the experts how investors should adjust their portfolios. Here's what they said.
What's on the menu for your portfolio? Morningstar equity analyst Mitchell Corwin has pinpointed five food-producing "standouts" with stocks at reasonable prices.
This could be the sector to own by next fall's presidential election.
In the week ahead, traders say the dysfunction in credit markets will continue to dominate, and they expect the stock market to keep testing lows in choppy trading.
I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...
A tumbling US dollar and surging oil prices are bad news for consumers. But for smart investors, there are opportunities to profit.
The largest increase in wholesale inflation in 26 years has left many investors wondering how to protect their portfolios. CNBC asked the market pros what they would do.
Sarat Sethi thinks investors should feed their portfolios food stocks. "We're putting money into food stocks, which are necessities, not discretionary items," the partner and portfolio manager for Douglas C. Lane and Associates told CNBC.
The world's biggest drug company is spending chump change to take out a little biotech at a 118 percent premium. Pfizer, which has a cash hoard of more than $20 billion, is plunking down a paltry (for Pfizer, that is) $195 million in cash money to buy Encysive Pharmaceuticals.
We ask the boss at Spam maker Hormel, why the stay-at-home eating trade is working?
European markets have recovered in the past two hours after a rough start. Credit Suisse roiled the markets early, as it announced $2.85 billion in writedowns -- just a few days after posting relatively strong fourth-quarter profit...
YouTube threw a coming out party of sorts to hundreds of top ad industry execs in New York City this week. The event was called 'Videocracy,' and it's the largest ever advertiser event thrown by Google which bought YouTube for $1.6 billion dollars two years ago.
U.S. stocks snapped a three-day losing streak Thursday, led by strong gains in the financial and retail sectors.
U.S. stocks turned firmly higher Thursday afternoon as bargain hunters scooped up undervalued stocks following three straight down days. Bank and retail stocks advanced. Even battered tech Cisco recovered.
U.S. stocks wavered Thursday as reports on January retail sales and jobless claims stirred recessionary fears. Tech stocks were under pressure after Cisco said consumers have become increasingly cautious. Retailers jumped.
There are two kinds of companies in the market – cyclical and secular. One of the most important moves in the game is to know when to shift money from one to the other.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Most companies this morning reported disappointing earnings, and a few highlighted the impact of inflation on their bottom line. 1) Morgan Stanley reported a loss of $3.61 vs. a consensus of a loss of $0.39.